Elevance Health (ELV) April and May options active as share price up 4%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Elevance (ELV) PT Raised to $575 at RBC Capital
April 19, 2024 6:46 AM EDTRBC Capital analyst Ben Hendrix raised the price target on Elevance (NYSE: ELV) to $575.00 (from $574.00) while maintaining a Outperform rating.
The analyst comments "Elevance again outperforms against a difficult managed care backdrop, with utilization across the benefit businesses tracking in line with expectations.... More
Elevance (ELV) PT Raised to $605 at UBS
April 19, 2024 6:36 AM EDTUBS analyst AJ Rice raised the price target on Elevance (NYSE: ELV) to $605.00 (from $585.00) while maintaining a Buy rating.
The analyst comments "ELV provided a few more details around its recently announced CDR partnership, noting that the care delivery entity will start... More
Elevance (ELV) PT Raised to $600 at Wells Fargo
April 19, 2024 5:57 AM EDTWells Fargo analyst Stephen Baxter raised the price target on Elevance (NYSE: ELV) to $600.00 (from $557.00) while maintaining a Overweight rating.
The analyst comments "ELV's 1Q24 results were strong and earnings quality appears high. Story remains fairly clean from our perspective. Continued growth... More
